news
A first stage trial involving the experimental drug mavoglurant has…
25 January 2019 | By Iqra Farooq (Drug Target Review)
A first stage trial involving the experimental drug mavoglurant has shown early success in the treatment of gaze avoidance in fragile X syndrome patients...